CMS wants to introduce “..new Medicaid Drug Utilization Review (DUR) provisions designed to reduce opioid related fraud, misuse and abuse..” Docket Number: CMS-2482-P federalregister.gov/documents/2020…
H. Changes Related to the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act
Pg 17-18
s3.amazonaws.com/public-inspect…
Pg 17-18
s3.amazonaws.com/public-inspect…
“These proposals include standards that would enhance a states’ ability to identify or limit inappropriate prescribing of opioids if a beneficiary is already receiving medication assisted treatment for substance use disorder (SUD).” cms.gov/newsroom/press…
Is CMS giving states a very wide girth to “adopt” their own “individual standards” in reference to each state’s Drug Utilization Programs (DUR) as related to prescribing opioids to Medicaid patients- bypassing “specific” federal standards- passing the $ to the states, again?
